Resonance Health (RHT)

Shares / Stock Code


Stock Exchange / Sharemarket


Resonance Health (RHT) is an Australian healthcare company developing and commercialising magnetic resonance imaging (MRI) related diagnostic technologies. RHT's first product, FerriScan, is a non-invasive MRI based test, allowing measurement of iron levels in the liver. The FerriScan test involves an MRI scan followed by secure transmission of the images via the internet to RHT's analysis centre from anywhere in the world. The test requires no new equipment purchase by MRI centres.

Ferriscan was developed at the University of Western Australia's School of Physics by a team led by Professor Tim St. Pierre. The technology has received regulatory clearance to be marketed in the USA, Australia, UK and Europe. The company was listed on Australian Stock Market (ASX) on 23 October, 1987.

The Ferriscan service involves an MRI scan followed by an off-site processing of the images by RHT using patented technology to generate the liver iron concentration result. Data are transmitted electronically via a secure line to the RHT analysis centre from anywhere around the world.

Major customers include research institutes, pharmaceutical companies and hospitals, locally and overseas. Major competitors involve other health-technological companies that focus on imaging equipment. The Company’s subsidiaries are Resonance Health Analysis Services Pty Ltd, WA Private Health Care Services Pty Ltd and IVB Holdings Pty Ltd.

Resonance Health (RHT) Products and Services

  • Development and commercialisation of MRI based diagnostic tests.

Resonance Health (RHT) Locations and Subsidiaries

Resonance Health Head Office
1st Floor, 216 Stirling Highway, CLAREMONT,
Phone: (08) 92865300
Fax: 0892861179

Resonance Health (RHT) Share Price

Submitted by ASX Listed Company on 27 May, 2010 - 16:29